The Biotech is pretty flat in the last 7 days, but PureTech Health has stood out, gaining 5.5%. Unfortunately though, the industry is down 14% over the past 12 months. Looking forward, earnings are forecast to grow by 33% annually.
Has the U.K. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 23 May 2025 | UK£2.4b | UK£879.3m | -UK£91,881,151.42 | 13.6x | -25.9x | 2.7x |
Sun, 20 Apr 2025 | UK£2.1b | UK£876.4m | -UK£169,598,336.21 | 17x | -12.4x | 2.4x |
Tue, 18 Mar 2025 | UK£2.4b | UK£844.0m | -UK£277,000,446.53 | 18.4x | -8.7x | 2.9x |
Thu, 13 Feb 2025 | UK£2.7b | UK£842.1m | -UK£295,314,390.08 | 85.9x | -9.1x | 3.2x |
Sat, 11 Jan 2025 | UK£2.5b | UK£842.6m | -UK£296,893,058.52 | 71.9x | -8.4x | 3x |
Mon, 09 Dec 2024 | UK£2.7b | UK£841.4m | -UK£293,453,317.58 | 80.4x | -9.1x | 3.2x |
Wed, 06 Nov 2024 | UK£2.9b | UK£840.1m | -UK£292,366,884.42 | 94.1x | -9.8x | 3.4x |
Fri, 04 Oct 2024 | UK£2.9b | UK£840.1m | -UK£295,405,284.11 | 97.3x | -9.8x | 3.5x |
Sun, 01 Sep 2024 | UK£2.8b | UK£834.4m | -UK£289,119,256.88 | 30.4x | -9.8x | 3.4x |
Tue, 30 Jul 2024 | UK£2.7b | UK£838.0m | -UK£257,225,327.28 | 30.4x | -10.5x | 3.2x |
Thu, 27 Jun 2024 | UK£2.5b | UK£835.8m | -UK£273,709,418.56 | 29.8x | -9.1x | 3x |
Sat, 25 May 2024 | UK£3.0b | UK£836.7m | -UK£287,505,558.48 | 31.1x | -10.4x | 3.6x |
Mon, 22 Apr 2024 | UK£3.0b | UK£903.1m | -UK£201,990,058.31 | 28.8x | -14.9x | 3.3x |
Wed, 20 Mar 2024 | UK£3.1b | UK£897.7m | -UK£203,638,078.85 | 33.7x | -15x | 3.4x |
Fri, 16 Feb 2024 | UK£3.1b | UK£913.4m | -UK£198,102,426.30 | 30.4x | -15.7x | 3.4x |
Sun, 14 Jan 2024 | UK£6.3b | UK£1.3b | -UK£245,123,674.00 | 37.6x | -25.9x | 5x |
Tue, 12 Dec 2023 | UK£6.2b | UK£1.3b | -UK£245,936,057.00 | 36.4x | -25.1x | 4.9x |
Thu, 09 Nov 2023 | UK£6.4b | UK£1.3b | -UK£243,295,328.00 | 38.1x | -26.2x | 5x |
Sat, 07 Oct 2023 | UK£6.5b | UK£1.3b | -UK£250,796,637.00 | 37.9x | -26.1x | 5.1x |
Mon, 04 Sep 2023 | UK£6.7b | UK£1.3b | -UK£205,920,114.00 | 23.6x | -32.4x | 5.3x |
Wed, 02 Aug 2023 | UK£6.9b | UK£1.3b | -UK£209,123,684.00 | 23.6x | -33x | 5.5x |
Fri, 30 Jun 2023 | UK£6.7b | UK£1.3b | -UK£209,507,519.00 | 23.9x | -31.8x | 5.3x |
Sun, 28 May 2023 | UK£7.0b | UK£1.3b | -UK£205,061,887.00 | 23.3x | -34x | 5.5x |
Tue, 25 Apr 2023 | UK£7.2b | UK£1.2b | -UK£156,280,796.00 | 23.6x | -45.8x | 5.8x |
Thu, 23 Mar 2023 | UK£7.2b | UK£1.2b | -UK£155,766,153.00 | 25.3x | -46x | 5.8x |
Sat, 18 Feb 2023 | UK£7.5b | UK£1.2b | -UK£150,073,589.00 | 27.4x | -49.7x | 6.4x |
Mon, 16 Jan 2023 | UK£7.7b | UK£1.2b | -UK£140,681,116.00 | 28.5x | -54.7x | 6.6x |
Wed, 14 Dec 2022 | UK£7.5b | UK£1.2b | -UK£136,687,386.00 | 25x | -54.8x | 6.5x |
Fri, 11 Nov 2022 | UK£7.8b | UK£1.2b | -UK£141,258,899.00 | 23.4x | -55.2x | 6.7x |
Sun, 09 Oct 2022 | UK£7.2b | UK£1.2b | -UK£149,697,721.00 | 26.4x | -48.4x | 6.2x |
Tue, 06 Sep 2022 | UK£21.1b | UK£1.1b | -UK£146,946,087.00 | 33.3x | -143.4x | 18.9x |
Thu, 04 Aug 2022 | UK£7.5b | UK£1.1b | -UK£200,743,194.00 | 38x | -37.1x | 6.7x |
Sat, 02 Jul 2022 | UK£7.0b | UK£1.1b | -UK£175,260,183.00 | 36.1x | -39.7x | 6.2x |
Mon, 30 May 2022 | UK£7.2b | UK£1.1b | -UK£146,482,002.00 | 38.9x | -49.1x | 6.5x |
-49.1x
How does U.K. Biotech compare with similar industries?
GB Market | 1.09% | |
Healthcare | 2.57% | |
Biotech | -1.70% | |
Biotech | -1.70% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
FARN Faron Pharmaceuticals Oy | UK£2.35 | 9.3% +UK£24.9m | 22.1% | PE-13.4x | |
OXB Oxford Biomedica | UK£3.20 | 6.0% +UK£19.1m | -2.1% | PS2.6x | |
PRTC PureTech Health | UK£1.35 | 3.2% +UK£10.1m | -40.7% | PE8.2x | |
BVXP Bioventix | UK£29.00 | 5.5% +UK£7.8m | -32.6% | PE19.3x | |
SCLP Scancell Holdings | UK£0.099 | 7.0% +UK£6.7m | -2.0% | PE-6.4x |